Risk-based Treatment for Patients with First Relapse or Progression of Rhabdomyosarcoma - A Report from the Children’s Oncology Group.

PURPOSE: To evaluate risk and response based multi-agent therapy for patients with rhabdomyosarcoma (RMS) at first relapse. PATIENTS AND METHODS: Patients with RMS and measurable disease at first relapse with unfavorable risk (UR) features were randomized to a six-week Phase 2 window with one of two...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Cancer
Hoofdauteurs: Mascarenhas, Leo, Lyden, Elizabeth R., Breitfeld, Philip P., Walterhouse, David O., Donaldson, Sarah S., Rodeberg, David A., Parham, David M., Anderson, James R., Meyer, William H., Hawkins, Douglas S.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2019
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7069123/
https://ncbi.nlm.nih.gov/pubmed/31067356
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.32122
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items